Financial insights of PLUR

MyFinsight

For the quarter ending 2026-03-31, PLUR made $167K in revenue. -$5,548K in net income. Net profit margin of -3322.16%.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenues	167	198	316	358*
Cost of revenues	111	112	201	304*
Gross profit	56	86	115	54*
Research and development expenses	3,976	3,949	3,961	3,824*
Less participation by the national institute of allergy and infectious diseases, or niaid, the israeli innovation authority, or iia, and horizon europe	14	123	30	-356*
Research and development expenses, net	3,962	3,826	3,931	4,180*
General and administrative expenses	2,630	2,766	2,534	2,452*
Operating loss	-6,536	-6,506	-6,350	-6,578*
Financial income (expenses), net	-	-	-	-51*
Other financial income (expenses), net	593	-143	439	-
Interest expenses	237	231	229	-1,486*
Total financial income (expenses), net	356	-374	210	1,435*
Loss before taxes	-6,180	-6,880	-6,140	-5,143*
Tax benefit	-8	-8	-8	-1*
Net loss	-6,172	-6,872	-6,132	-5,142*
Net loss attributed to non-controlling interest	-624	-329	-282	-205*
Net loss attributed to shareholders	-5,548	-6,543	-5,850	-4,937

Basic EPS	-0.55	-0.71	-0.65	-0.684
Diluted EPS	-0.55	-0.71	-0.65	-0.684
Basic Average Shares	10,054,803	9,260,439	8,995,635	7,214,750
Diluted Average Shares	10,054,803	9,260,439	8,995,635	7,214,750

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.